{"nct_id":"NCT03690388","title":"A Study of Cabozantinib Compared With Placebo in Subjects With Radioiodine-refractory Differentiated Thyroid Cancer Who Have Progressed After Prior Vascular Endothelial Growth Factor Receptor (VEGFR) -Targeted Therapy","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-09","start_date":"2018-10-05","start_date_type":"ACTUAL","primary_completion_date":"2020-08-19","primary_completion_date_type":"ACTUAL","completion_date":"2026-07-31","completion_date_type":"ESTIMATED","phases":["PHASE3"],"tickers":["EXEL"]}